'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Jujutsu Kaisen Modulo has upped the intensity once again and shocked the fans with the latest reveal of Yuka Okkotsu's ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

“Paddy Power has had a hugely positive impact on the World Darts Championship over the past two years,” said PDC Chief Executive Matt Porter once the news was announced. “Their creativity, investment ...

Haupt is a health and wellness editor at TIME. Photo-Illustration by TIME (Source Images: Maryna Terletska—Getty Images, Nora Carol Photography/Getty Images, A. Martin UW Photography/Getty Images, ...

Ramanujan’s insights into pi are now guiding scientists toward a deeper understanding of how the universe works.

In] any piece of beautiful mathematics, you almost always find that there is a physical system which actually mirrors the ...